“bob-langer” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device 02/23/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Seventh Sense Biosystems Sucks In $10M for Simple Blood-Draw Device 11/18/16 Boston
MIT’s Bhatia Refocuses Spotlight on Gender Diversity in Biotech 09/12/16 Boston
Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More 08/26/16 National
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs 03/23/16 Boston
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact 12/16/15 Boston
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
SQZ Biotech Shifts to Therapy Development with $5M Series A 06/24/15 Boston
Where the Red Book Meets the Unicorn 06/22/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
To Back Startups, PureTech Heads Across the Pond For $160M London IPO 05/26/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Paul Maritz Brings Cloud Expertise to Nanobiosym With Investment 02/26/15 Boston
With $21M, Retooled Blend Whips up Mini-Smart Bombs For Cancer 01/07/15 Boston
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
With Wires and Electrodes, Tara Bio Builds a Heart on a Chip 11/12/14 New York
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Page 1 of 5 next page »